LINDSAY MCVAY: Open Payments
NPI 1649417668 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 55 payments from 15 companies in 2025. Trend: 2023 $1,046 · 2024 $722 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $256 |
| GlaxoSmithKline, LLC. | 14 | $142 |
| Lilly USA, LLC | 7 | $124 |
| ABBVIE INC. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: PREVNAR 20, ELIQUIS, MOUNJARO, TRELEGY ELLIPTA, NURTEC ODT, JARDIANCE, VRAYLAR, SHINGRIX.
Industry payments across OK — which companies pay providers there.
